Agentix (AGTX) Interest & Investment Income (2020 - 2024)

Agentix's (AGTX) quarterly Interest & Investment Income came in at $496.0 in Q1 2024, up 100.0% on a QoQ basis from $248.0 in Q3 2023.

Agentix (AGTX) Interest & Investment Income (2020 - 2024) Analysis & Trends

Agentix (AGTX) has 3 years of Interest & Investment Income data on file, last reported at $496.0 in Q1 2024.

Quarterly Interest & Investment Income changed N/A year-over-year to $496.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $744.0 (changed N/A YoY) and the FY2024 annual result came in at $248.0, changed N/A from the prior year.
Interest & Investment Income climbed to $496.0 in Q1 2024, from $248.0 in the prior quarter.
In the past five years, Interest & Investment Income ranged from a high of $496.0 in Q1 2024 to a low of -$5.0 in Q4 2020.
A 3-year average of $246.33 and a median of $248.0 in 2023 frame the typical range for Interest & Investment Income.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	120.60 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-48.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	48.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	67.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	27.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	28.14 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	115.94 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	10.98 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	5.13 Mn
10	Agentix	801,339.00	801,301.00	-	-

Download Data